Principles of allostasis: Optimal design, predictive regulation, pathophysiology, and rational therapeutics

Allostasis, Homeostasis, and the Costs of Physiological Adaptation

Volumn , Issue , 2015, Pages 17-64

  Sterling, Peter ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84954243686     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9781316257081.004     Document Type: Chapter

References (120)

1. Adolphs, R., Tranel, D., Damasio, H., Damasio, A. (1994). Impaired recognition of emotion in facial expressions following bilateral damage to the human amygdala. Nature 372:669-72.
2. Alexander, R. M. (1996). Optima for Animals. Princeton: Princeton University Press.
3. Ashrafi, K., Chang, F. Y., Watts, J. L., Graser, A. G., Kamath, R. S., Ahringer, J., Ruvkun, G. (2001). Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature 421:268-72.
4. Baker, L., Minuchin, S., Rosman, B. (1974). The use of beta-adrenergic blockade in the treatment of psychosomatic aspects of juvenile diabetes mellitus. In: Advances in Beta-Adrenergic Blocking Therapy (ed. J. A. Snart), pp. 67-80. Princeton: Princeton Excerpta Medica.
5. Bateson, G., Mead, M. (1952). Trance and Dance in Bali. Documentary.
6. Berkman, L. F., Kawachi, I. (2000). Social Epidemiology. New York NY: Oxford University Press.
7. Berkson, J. (1962). Mortality and marital status. Reflections on the derivation of etiology from statistics. Am J Pub Health 52:1318.
8. Bernik, T. R., Friedman, S. G., Ochani, M., DiRaimo, R., Ulloa, L., Yang, H., Sudan, S., Czura, C. J., Ivanova, S. M., Tracy, K. J. (2002). Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med 195:781-8.
9. Bevan, A. T., Honour, A. J., Stott, F. H. (1969). Direct arterial pressure recording in unrestricted man. Clin Sci 36:329.
10. Blalock, J. E. (2002). Harnessing a neural-immune circuit to control inflammation and shock. J Exp Med 195:F25-8.
11. Blumenthal, S., Epps, R. P., Heavenrich, R., Lauer, R. M., Lieberman, E., Mirkin, B., Mitchell, S. C., Boyar-Naito, V., O’Hare, D., McFate-Smith, W., Tarazi, R. C., Upson, D. (1977). Report of the task force on blood pressure control in children. Pediatrics 59:797.
12. Bockoven, J. S. (1956). Moral treatment in American psychiatry. J Nerv Ment Dis 124:167-321.
13. Brenner, R., Peréz, G. J., Bonev, A. D., Eckman, D. M., Kosek, J. C., Wiler, S. W., Patterson, A. J., Nelson, M. T., Aldrich, R. W. (2000). Vasoregulation by the beta1 subunit of the calcium-activated potassium channel. Nature 407:870-6.
14. Brownlee, M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-20.
15. Brunner, E. J. (2000). Toward a new social biology. In: Social Epidemiology (ed. L. Berkman, I. Kawachi), pp. 306-331. New York: Oxford University Press.
16. Buchman, T. G. (2002). The community of the self. Nature 420:246-51.
17. Cannon, W. B. (1920). Bodily Changes in Pain, Hunger, Fear and Rage: An Account of Recent Researches into the Function of Emotional Excitement. New York: Appleton.
18. Cannon, W. B. (1935). Stresses and strains of homeostasis. Am J Med Sci 189:1-10.
19. Carretero, O. A., Oparil, S. (2000a). Essential hypertension. Part I: Definition and etiology. Circulation 101:329-35.
20. Carretero, O. A., Oparil, S. (2000b). Essential hypertension. Part II: Treatment. Circulation 101:446-53.
21. Cotman, C. W., Berchtold, N. C. (2002). Exercise: A behavioral intervention to enhance brain health and plasticity. Trends Neurosci 25:295-301.
22. Dallman, M. F. (2003). Stress by any other name… ? Horms Behav 43:18-20.
23. Dallman, M. F., Pecoraro, N., Akana, S. F., la Fleur, S. E., Gomez, F., Houshyar, H., Bell M. E., Bhatnagar, S., Laugero, K. D., Manalo, S. (2003). Chronic stress and obesity: a new view of “comfort food.” Proc Natl Acad Sci U S A 100:11696-701.
24. de la Fuente-Fernández, R., Ruth, T. J., Sossi, V., Schulzer, M., Calne, D. B., Stoessl, A. J. (2001). Expectation and dopamine release: Mechanism of the placebo effect in Parkinson’s disease. Science 293:1164-6.
25. de la Fuente-Fernández, R., Stoessl, A. J. (2002). The placebo effect in Parkinson’s disease. Trends Neurosci 25:302-6.
26. Denton, D. (1993). Control mechanisms. In: The Logic of Life (ed. C. A. R Boyd, D. Noble), pp. 113-46. Oxford: Oxford University Press.
27. Dhingra, N. K., Kao, Y.-H., Sterling, P., Smith, R. G. (2003). Contrast threshold of a brisk-transient ganglion cell in vitro. J Neurophysiol 89:2360-9.
28. Diamond, J. (1993). Evolutionary physiology. In: The Logic of Life (ed. C. A. R. Boyd, D. Noble), pp 89-111. New York: Oxford University Press.
29. Diamond, J. (1999). Guns, Germs, and Steel: The Fates of Human Societies. New York: W. W. Norton & Sons.
30. Diamond, J. (2003). The double puzzle of diabetes. Nature 423:599-602.
31. Elbert, T., Rockstroh, B. (2003). Stress factors. Nature 421:477-8.
32. Ernst, M. O., Banks, M. S. (2002). Humans integrate visual and haptic information in a statistically optimal fashion. Nature 415:429-33.
33. Eyer, J. (1975). Hypertension as a disease of modern society. Int J Health Serv 5:539-58.
34. Eyer, J. (1977). Prosperity as a cause of death. Int J Health Serv 7:125-50.
35. Eyer, J., Sterling, P. (1977). Stress-related mortality and social organization. Rev Radical Political Econ 9:1-44.
36. Fairhall, A. L., Lewen, G. D., Bialek, W., de Ruyter van Steveninck, R. (2001). Efficiency and ambiguity in an adaptive neural code. Nature 412:787-92.
37. Farooqi, I. S., Matarese, G., Lord, G. M. Keogh, J. M., Lawrence, E., Agwu, C., Sanna, V., Jebb, S. A., Perna, F., Fontana, S., Lechler, R. I., DePaoli, A. M., O’Rahilly, S. (2002). Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 110:1093-1103.
38. Fehr, E., Fischbacher U. (2003). The nature of human altruism. Nature 425:785-791.
39. Field, G. D., Rieke, F. (2002). Nonlinear signal transfer from mouse rods to bipolar cells and implications for visual sensitivity. Neuron 34:773-85.
40. Fiorello, C. D., Tobler, P. N., Schultz, W. (2003). Discrete coding of reward probability and uncertainty by dopamine neurons. Science 299:1898-1902.
41. Flier, J. S. (2002). Is brain smpathetic to bone? Nature 420:619-22.
42. Fluharty, S. J. (2002). Neuroendocrinology of body fluid homeostasis. In: Hormones, Brain and Behavior, pp. 525-569. New York: Elsevier Science.
43. Friedman, M. I., Ji, H., Graczyk-Milbrandt, G., Osbakken, M. D., Rawson, N. E. (1998). Hepatic sensing in the control of food intake: unresolved issues. In: Liver and Nervous System (ed. D. Häussinger, K. Jungermann), pp. 220-29. London: Kluwer Academic Press.
44. Geisler, W. S., Diehl, R. L. (2002). Bayesian natural selection and the evolution of perceptual systems. Philos Trans R Soc Lond (Biol) 357:419-48.
45. Geisler, W. S., Diehl, R. L. (2003). A Bayesian approach to the evolution of perceptual and cognitive systems. Cogn Sci 118:1-24.
46. Gelman, S. (1999). Medicating Schizophrenia: A History. Piscataway, NJ: Rutgers University Press.
47. Glimcher, P.W. (2002). Decisions, decisions, decisions: Choosing a biological science of choice. Neuron 36:323-32.
48. Gordon-Larsen, P., Zenel, B. S., Johnston, F. E. (1997). Secular changes in stature, weight, fatness, overweight, and obesity in urban African American adolescents from the mid-1950’s to the mid-1990’s. Am J Hum Biol 9:675-88.
49. Greenblatt. M., York, R. H., Brown, E. L. (1955). From Custodial to Therapeutic Patient Care in Mental Hospitals: Explorations in Social Treatment. New York: Russell Sage Foundation.
50. Grob, G. N. (1966). The State and the Mentally Ill. A History of Worcester State Hospital in Massachusetts, 1830-1920. Chapel Hill: University of North Carolina Press.
51. Hammond, K. A., Diamond, J. (1997). Maximal sustained energy budgets in humans and animals. Nature 386:457.
52. Harris, A. H., Gilliam, W. J., Findley, J. D., Brady, J. V. (1973). Instrumental conditioning of large magnitude. Daily, 12-hour blood pressure elevations in the baboon. Science 182:175-77.
53. Henry, J. P., Meehan, J. P., Stevens, P. M. (1967). The use of psychosocial stimuli to induce prolonged systolic hypertension in mice. Psychosom Med 29:408.
54. Hill, J. O., Wyatt, H. R., Reed, G.W., Peters, J. C. (2003). Obesity and the environment: where do we go from here? Science 299:853-5.
55. Hochachka. P. W., Somero, G. N. (2002). Biochemical Adaptation: Mechanism and Process in Physiological Evolution. New York: Oxford University Press.
56. Ikeda, H., Heinke, B., Ruscheweyh, R., Sandkühler, J. (2003). Synaptic plasticity in spinal lamina I projection neurons that mediate hyperalgesia. Science 299:1237-40.
57. Kohn, L. T., Corrigan, J. M., and Donaldson M. S. (eds) (2000). Institute of Medicine. To err is human: building a safer health system.Washington DC, National Academy Press.
58. Koob, G. F., LeMoal, M. (2001). Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24:172-89.
59. Koshland, D. E. Jr. (1987). Switches, thresholds and ultrasensitivity. Trends Biochem Sci 12:225-9.
60. Koshland, D. E. Jr., Goldbeter, A., Stock, J. B. (1982). Amplification and adaptation in regulatory and sensory systems. Science 217:220-5.
61. Laakso, A., Mohn, A. R., Gainetdinov, R. R., Caron, M. G. (2002). Experimental genetic approaches to addiction. Neuron 36:213-28.
62. LaBar, K. S., Gatenby, J. C., Gore, J. C., LeDoux, J. E., Phelps, E. A. (1998). Human amygdala activation during conditioned fear acquisition and extinction: a mixedtrial fMRI study. Neuron 20:937-45.
63. Laughlin, S. (1981). A simple coding procedure enhances a neuron’s information capacity. Z Naturforsch C 36:910-12.
64. Laughlin, S. B. (1994). Matching coding, circuits, cells, and molecules to signals: General principles of retinal design in the fly’s eye. Prog Ret Eye Res 13:165-96.
65. Lennie, P. (2003). The cost of cortical computation. Curr Biol 13:493-7.
66. Levit, K., Smith, C., Cowan, C., Lazenby, H., and Martin, A. (2000). Inflation spurs health spending in 2000. Baltimore MD, National Health Statistics Group, Office of the Actuary, Centers for Medicare and Medicaid Services.
67. Lücher, C., Frerking, M. (2003). Restless AMPA receptors: Implications for synaptic transmission and plasticity. Trends Neurosci 24:665-70.
68. Mark. V. H., Ervin, F. R. (1970). Violence and the Brain. New York: Harper & Row.
69. Marmot, M. (2000). Multilevel approaches to understanding social determinants. In: Social Epidemiology (ed. L. F. Berkman, I. Kawachi), pp. 349-67. New York: Oxford University Press.
70. Mason, J.W. (1968). Organization of endocrine mechanisms. Psychosom Med 30:565.
71. Mason, J.W. (1971). A reevaluation of the concept of “nonspecificity” in stress theory. J Psychiat Res 8:323.
72. Mason, J. W. (1972). Organization of psychoendocrine mechanisms. In: Handbook of Psychophysiology (ed. N. S. Greenfield, R. A. Sternbach), pp. 3-91. New York: Holt, Rhinehart & Winston.
73. Massey, D. S., Denton, N. A. (1994). American Apartheid. Cambridge: Harvard University Press.
74. McEwen, B. (2002). The End of Stress As We Know It. Joseph Henry Press/Dana Press. Washington DC.
75. Minuchin, S. (1974). Families and Family Therapy. Cambridge: Harvard University Press.
76. Moller, D. E. (2001). New drug targets for type 2 diabetes and the matabolic syndrome. Nature 414:821-7.
77. Montague, P. R., Berns, G. S. (2002). Neural economics and the biological substrates of valuation. Neuron 36:265-84.
78. Mrosovsky, N. (1990). Rheostasis. The Physiology of Change. New York: Oxford University Press.
79. Nauta, W. J. H. (1971). The problem of the frontal lobe: A reinterpretation. J Psychiatr Res 8:167-87.
80. Nestle, M. (2002). Food Politics. Berkeley and Los Angeles: University of California Press.
81. National Institutes of Health. (1997). The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. NIH Publications, Betaesda, MD.
82. Orfield, G. (2001). Schools More Separate: Consequences of a Decade of Resegregation. Cambridge: Harvard Civil Rights Project, Harvard University.
83. Ornish, D., Brown, S. E., Scherwitz, L.W., Billings, J. H., Armstrong, W. T., Ports, T. A., McLanahan, S. M., Kirkeeide, R. L., Brand, R. J., Gould, K. L. (1990). Can lifestyle changes reverse coronary heart disease? Lancet 336:129-33.
84. Petrovic, P., Kalso, E., Petersson, K. M., Ingvar, M. (2002). Placebo and opioid analgesia - imaging a shared neuronal network. Science 295:1737-40.
85. Phillips, P. E. M., Stuber, G. D., Helen, M. L. A.V., Wightman, R. M., Carelli, R. M. (2003). Subsecond dopamine release promotes cocaine seeking. Nature 422:614-18.
86. Rieke, F., Warland, D., de Ruyter van Steveninck, R., Bialek, W. (1999). Spikes: Exploring the Neural Code. Cambridge: MIT Press.
87. Roenneberg, T., Merrow, M. (2003). The network of time: Understanding the molecular circadian system. Curr Biol 13:R198-207.
88. Rosenberg, R. N., Prusiner, S. B., DiMauro, S., Barchi, R. L. (1997). Molecular and Genetic Basis of Neurological Disease. Boston: Butterworth-Heineman.
89. Sacks, F. M., Svetkey, L. P., Vollmer, W. M., Appel, L. J., Bray, G. A., Harsha, D., Obarzanek, E., Conlin, P. R., Miller, E. R. I., Simons-Morton, D. G., Karanja, N., Lin, P.-H. (2001). Effects of blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. New Engl J Med 344:3-9.
90. Sakmann, B., Creutzfeldt, O. D. (1969). Scotopic and mesopic light adaptation in the cat’s retina. Pflügers Arch 313:168-85.
91. Saltiel, A. R., Kahn, C. R. (2001). Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799-806.
92. Saper, C. B., Chou, T. C., Elmquist, J. K. (2002). The need to feed: Homeostatic and hedonic control of eating. Neuron 36:199-211.
93. Sapolsky, R. M. (1998). Why Zebras Don’t Get Ulcers. New York: W. H. Freeman.
94. Schlosser, E. (2002). Fast Food Nation. New York: HarperCollins.
95. Schulkin, J. (1999). The Neuroendocrine Regulation of Behavior. New York: Cambridge University Press.
96. Schulkin, J. (2003a). Allostasis: A neural behavioral perspective. Horm Behav 43:21-7.
97. Schulkin, J. (2003b). Rethinking Homeostasis: Allostatic Regulation in Physiology and Pathophysiology. Cambridge: MIT Press.
98. Schulkin, J., McEwen, B. S., Gold, P.W. (1994). Allostasis, amygdala, and anticipatory angst. Neurosci Biobehav Rev 18:385-96.
99. Schultz, W. (2002). Getting formal with dopamine and reward. Neuron 36:241-63.
100. Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., Baskin, D. G. (2000). Central nervous system control of food intake. Nature 404:661-72.
101. Smith, A. (1937). The Wealth of Nations. New York: Random House, pp. 734-735.
102. Sterling, P. (1978). Ethics and effectiveness of psychosurgery. In: Controversy in Psychiatry (ed. J. P. Bradie, H. K. Brodie), pp. 126-60. Philadelphia: W. B. Saunders.
103. Sterling, P. (1979). Psychiatry’s drug addiction. The New Republic, December 8th. pp. 14-18.
104. Sterling, P. (2004). How retinal circuits optimize the transfer of visual information. In: The Visual Neurosciences (ed. L. M. Chalupa, J. S. Werner), pp. 243-68. Cambridge: MIT Press.
105. Sterling, P., Eyer, J. (1981). Biological basis of stress-related mortality. Soc Sci Med 15E:3-42.
106. Sterling, P., Eyer, J. (1988). Allostasis: A new paradigm to explain arousal pathology. In: Handbook of Life Stress, Cognition and Health (ed. S. Fisher, J. Reason), pp. 629-49. New York: John Wiley & Sons.
107. Takeda, S., Elefteriou, F., Levasseur, R., Liu, X., Zhao, L., Parker, K. L., Armstrong, D., Ducy, P., Karsenty, G. (2002). Leptin regulates bone formation via the sympathetic nervous system. Cell 111:305-17.
108. Taylor, C. R., Weibel, E. R. (1981). Design of the mammalian respiratory system. I. Problem and strategy. Respir Physiol 44:1-10.
109. Taylor, F. W. (1967). Principles of Scientific Management. New York: Norton, pp. 24-25.
110. Tracy, K. J. (2002). The inflammatory reflex. Nature 420:853-9.
111. Tuke, S. (1964). Description of the Retreat, 1813. Reprinted with Introduction by R. Hunter and I. Macalpine. London: Dawson of Pall Mall.
112. Valenstein, E. S. (1973). Brain Control. New York: John Wiley & Sons.
113. Valenstein, E. S. (1986). Great and Desperate Cures: The Rise and Decline of Psychosurgery and Other Radical Treatments for Mental Illness. New York: Basic Books.
114. Waldron, I. (1979). A quantitative analysis of cross-cultural variation in blood pressure and serum cholesterol. Psychosom Med 41:582.
115. Weibel, E. R. (2000). Symmorphosis. Cambridge: Harvard University Press.
116. Wilson, E. O. (1984). Biophilia. Cambridge: Harvard University Press.
117. Wilson, F. H., Disse-Nicodème, S., Choate, K. A., Ishikawa, K., Nelson-Williams, C., Desitter, I., Gunel, M., Milford, D. V., Lipkin, G. W., Achard, J.-M., Feely, M. P., Dussol, B., Berland, Y., Unwin, R. J., Mayan, H., Simon, D. B., Farfel, Z., Jeunemaitre, X., Lifton, R. P. (2001). Human hypertension caused by mutations in WNK kinases. Science 293:1107-12.
118. Wise, R. A. (2003). Brain reward circuitry: Insight from unsensed incentives. Neuron 36:229-40.
119. Zhu, Y., Bian, Z., Lu, P., Karas, R. H., Bao, L., Cox, D., Hodgin, J., Shaul, P.W., Thorén, P., Smithies, O., Gustafsson, J., Mendelsohn, M. E. (2002). Abnormal vacular function and hypertension in mice deficient in estrogen receptor beta. Science 295:505-8.
120. Zimmet, P., Alberti, K. G. M. M., Shaw, J. (2001). Global and societal implications of the diabetes epidemic. Nature 414:782-7.